Key Updates in Ovarian Cancer From ESMO 2023 Key Updates in Ovarian Cancer From ESMO 2023

Highlights in ovarian cancer from ESMO 2023 include results on first-line use of a PARP inhibitor and on the addition of immunotherapy to platinum-based chemotherapy, and PARP inhibition after relapse.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news